Lateral diffusion of GFP-tagged H2Ld molecules and of GFP-TAP1 reports on the assembly and retention of these molecules in the endoplasmic reticulum.

Lateral diffusion of GFP-tagged H2Ld molecules in the ER membrane reports on their interaction with the TAP complex during synthesis and peptide loading. Peptide-loaded H2Ld molecules diffuse rapidly, near the theoretical limit for proteins in a bilayer. However, these molecules are retained in the ER for some time after assembly. H2Ld molecules, associated with the TAP complex, diffuse slowly, as does GFP-tagged TAP1. This implies that the association of H2Ld molecules with the TAP complex is stable for at least several minutes. It also suggests that the TAP complex is very large, perhaps containing hundreds of proteins.

[1]  J. E. V. van Leeuwen,et al.  Deglucosylation of N-linked glycans is an important step in the dissociation of calreticulin-class I-TAP complexes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Solheim,et al.  Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. , 1997, Journal of immunology.

[3]  E. Elson,et al.  Analysis of cell surface interactions by measurements of lateral mobility. , 1979, Journal of supramolecular structure.

[4]  J. Yewdell,et al.  Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. , 1992, Advances in immunology.

[5]  D. Dewitt,et al.  The Membrane Association Sequences of the Prostaglandin Endoperoxide Synthases-1 and -2 Isozymes* , 1998, The Journal of Biological Chemistry.

[6]  A. Linstedt,et al.  Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa. , 1993, Molecular biology of the cell.

[7]  A. Singer,et al.  Persistence of glucose residues on core oligosaccharides prevents association of TCR alpha and TCR beta proteins with calnexin and results specifically in accelerated degradation of nascent TCR alpha proteins within the endoplasmic reticulum. , 1994, The EMBO journal.

[8]  S. Gordon.  The Legacy of cell fusion , 1994 .

[9]  P. A. Peterson,et al.  MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains , 1996, The Journal of experimental medicine.

[10]  A. Helenius,et al.  Interactions between Newly Synthesized Glycoproteins, Calnexin and a Network of Resident Chaperones in the Endoplasmic Reticulum , 1997, The Journal of cell biology.

[11]  J. Lippincott-Schwartz,et al.  Diffusional Mobility of Golgi Proteins in Membranes of Living Cells , 1996, Science.

[12]  B. Carreno,et al.  TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man. , 1995, Journal of immunology.

[13]  J. Miyazaki,et al.  Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells. , 1988, Journal of immunology.

[14]  G. Evans,et al.  In vitro mutagenesis of a mouse MHC class I gene for the examination of structure-function relationships. , 1985, Journal of immunology.

[15]  H. Eisen,et al.  A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein , 1992, Cell.

[16]  G Büldt,et al.  Surface structures of native bacteriorhodopsin depend on the molecular packing arrangement in the membrane. , 1999, Journal of molecular biology.

[17]  R. Tampé,et al.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. , 1997, Science.

[18]  S. Joyce.  Traffic control of completely assembled MHC class I molecules beyond the endoplasmic reticulum. , 1997, Journal of molecular biology.

[19]  S. Tonegawa,et al.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.

[20]  J. Beck,et al.  Slower processing, weaker beta 2-M association, and lower surface expression of H-2Ld are influenced by its amino terminus. , 1986, Journal of immunology.

[21]  E. Degen,et al.  Participation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules , 1991, The Journal of cell biology.

[22]  A. Helenius,et al.  Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Hughes,et al.  Extraction of membrane microviscosity from translational and rotational diffusion coefficients. , 1982, Biophysical journal.

[24]  P. Cresswell,et al.  Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.

[25]  R. Scheller,et al.  SNARE Membrane Trafficking Dynamics In Vivo , 1999, The Journal of cell biology.

[26]  J. Yewdell,et al.  Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Solheim,et al.  Calreticulin and calnexin interact with different protein and glycan determinants during the assembly of MHC class I. , 1998, Journal of immunology.

[28]  D. Marguet,et al.  Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses. , 1999, Cellular immunology.

[29]  R F Standaert,et al.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.

[30]  R. J. Cohen,et al.  Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. , 1994, Immunity.

[31]  D. R. Lee,et al.  The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure , 1991, The Journal of experimental medicine.

[32]  J. Rothbard,et al.  A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes , 1989, Nature.

[33]  M. Jackson,et al.  High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[35]  K. Marusina,et al.  Allelic variation in the mouse Tap-1 and Tap-2 transporter genes. , 1997, Journal of immunology.

[36]  M. Farquhar,et al.  Cell type-dependent variations in the subcellular distribution of alpha- mannosidase I and II , 1993, The Journal of cell biology.

[37]  T. Elliott,et al.  Evidence for successive peptide binding and quality control stages during MHC class I assembly , 1998, Current Biology.

[38]  A. Bai,et al.  The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules. , 1997, Journal of immunology.

[39]  K. Ozato,et al.  Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. , 1980, Journal of immunology.

[40]  P. A. Peterson,et al.  Interaction of MHC class I molecules with the transporter associated with antigen processing. , 1994, Science.

[41]  J. Monaco,et al.  Physical and Functional Association of the Major Histocompatibility Complex Class I Heavy Chain α3 Domain with the Transporter Associated with Antigen Processing , 1998, The Journal of experimental medicine.

[42]  M. Edidin,et al.  Micrometer-scale domains in fibroblast plasma membranes , 1987, The Journal of cell biology.

[43]  U. Utz,et al.  Analysis of the Expression of Peptide–Major Histocompatibility Complexes Using High Affinity Soluble Divalent T Cell Receptors , 1997, The Journal of experimental medicine.

[44]  J. Howard.  Supply and transport of peptides presented by class I MHC molecules. , 1995, Current opinion in immunology.

[45]  M. Mann,et al.  ER‐60, a chaperone with thiol‐dependent reductase activity involved in MHC class I assembly , 1998, The EMBO journal.

[46]  R. Germain,et al.  MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon , 1991, Nature.

[47]  E. Szczesna-Skorupa,et al.  Mobility of cytochrome P450 in the endoplasmic reticulum membrane. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Monaco,et al.  Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.